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Regulation of chromatin structure via histone modifi-
cation has recently received intense attention.
Here, we demonstrate that the chromatin-modifying
enzyme histone deacetylase 2 (Hdac2) functions
with a small homeodomain factor, Hopx, to mediate
deacetylation of Gata4, which is expressed by
cardiac progenitor cells and plays critical roles in
the regulation of cardiogenesis. In the absence of
Hopx and Hdac2 in mouse embryos, Gata4 hyper-
acetylation is associated with a marked increase
in cardiac myocyte proliferation, upregulation of
Gata4 target genes, and perinatal lethality. Hdac2
physically interacts with Gata4, and this interaction
is stabilized by Hopx. The ability of Gata4 to transac-
tivate cell cycle genes is impaired by Hopx/Hdac2-
mediated deacetylation, and this effect is abrogated
by loss of Hdac2-Gata4 interaction. These results
suggest that Gata4 is a nonhistone target of Hdac2-
mediated deacetylation and that Hdac2, Hopx, and
Gata4 coordinately regulate cardiac myocyte prolif-
eration during embryonic development.
INTRODUCTION
In the heart, cardiac myocyte proliferation is tightly controlled
during embryonic development as the heart grows and simulta-
neously functions to circulate blood and nutrients. Cardiac
myocyte progenitors rapidly proliferate during early stages of
development and contribute to the trabecular and compact
myocardium (Ieda et al., 2009; Pasumarthi and Field, 2002).
During late gestation, myocytes progressively lose the ability to
proliferate, and shortly after birth the vast majority of cardiac
myocyte proliferation ceases, as the heart transitions from
hyperplastic to hypertrophic growth.450 Developmental Cell 19, 450–459, September 14, 2010 ª2010 ElsTheGata family of transcription factors, Gata1–6, are known to
be critical for embryonic development, cell growth, and differen-
tiation. Gata transcription factors are defined by an evolutionarily
conserved DNA-binding domain consisting of two zinc finger
motifs that recognize the consensus-binding site WGATAR
(Ko and Engel, 1993; Merika and Orkin, 1993). Gata1–3 are
predominantly expressed in hematopoietic cells, whereas
Gata4–6 are expressed in several mesoderm- and endoderm-
derived tissues (Charron and Nemer, 1999). Gata4 is one of the
earliest genes expressed by specified cardiac precursors at
the cardiac crescent stage of mouse development (Arceci
et al., 1993; Kelley et al., 1993). Global loss of Gata4 in mice
causes embryonic lethality at E9.5 as a result of severe defects
in the extraembryonic endoderm and aberrant heart and foregut
morphogenesis (Kuo et al., 1997; Molkentin et al., 1997). Studies
involving tissue-specific loss of Gata4 in murine cardiac
myocytes have demonstrated a critical role for Gata4 in embry-
onic myocyte proliferation (Zeisberg et al., 2005). Mice lacking
Gata4 in the anterior heart field (AHF), for example, die by
E13.5 as a result of significant right ventricular and interventric-
ular septal myocyte proliferation defects (Rojas et al., 2008).
Gata4 null cardiomyocytes show downregulation of a wide array
of cell cycle–associated genes, some of which are direct
transcriptional targets of Gata4, including cyclinD2 and cdk4
(Rojas et al., 2008).
Gata4 activity is modulated in response to a number of intra-
cellular signaling pathways, and Gata4 protein is subject to
posttranslational modifications, including phosphorylation and
acetylation (Kawamura et al., 2005; Liang et al., 2001). The
histone acetyl transferase (HAT) p300 is able to acetylate
Lys311, 318, 320, and 322 of Gata4, resulting in enhanced
DNA binding and transcriptional activity (Takaya et al., 2008).
In transgenic mice, p300 overexpression in the heart induces
Gata4 acetylation and cardiac hypertrophy (Miyamoto et al.,
2006; Yanazume et al., 2003). Interestingly, p300 null mice die
at E9.5 exhibiting defects in proliferation and cardiac develop-
ment (Yao et al., 1998). Mechanisms for Gata4 deacetylation
have, to our knowledge, not been previously described.
Protein deacetylation can be mediated by members of the
histone deacetylase (Hdac) family (Glozak et al., 2005). Onevier Inc.
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mammalian Hdacs are classified into five subfamilies, class I
(Hdac1, 2, 3, and 8), class IIa (Hdac4, 5, 7, and 9), class IIb Hdacs
(Hdac6 and Hdac10), class III (sirtuins), and class IV (Hdac11) (de
Ruijter et al., 2003; Gregoretti et al., 2004). Hdacs lack intrinsic
DNA-binding ability and are recruited to target genes via their
incorporation into large multiprotein transcriptional complexes,
as well as direct association with transcriptional activators or
repressors (Grunstein, 1997). Eukaryotic Hdacs can deacetylate
both histone and nonhistone substrates (Ekwall, 2005; Glozak
et al., 2005).Gene inactivation studies inmice havedemonstrated
potent functions for several class I and II Hdacs in cardiac devel-
opment and in the regulation of cardiac hypertrophy and metab-
olism (Haberland et al., 2009). Recently, we have shown that
global loss of Hdac2 results in partial perinatal lethality due to
cardiac developmental defects that include enhanced cardiac
myocyte proliferation (Trivedi et al., 2007a). Combined loss of
Hdac1 and Hdac2 in cardiac myocytes results in complete peri-
natal lethality andcardiacdefects that aremore severe than those
seen in either individual knock-out (Montgomery et al., 2007).
We have previously shown that Hdac2 is able to physically
interact with an atypical homeodomain protein called Hopx,
which is expressed in the developing heart (Kook et al., 2003).
Hopx is a 73–amino acid protein that includes a 60–amino acid
motif homologous to the homeodomain of Hox transcription
factors (Kook and Epstein, 2003). Unlike most other homeodo-
main proteins, Hopx is unable to bind DNA because it lacks
certain conserved amino acid residues that are required for
protein-DNA interactions (Kook et al., 2006). However, Hopx is
a nuclear protein that can function to modulate cardiac gene
transcription by recruiting Hdacs (Kook et al., 2003). Inactivation
of Hopx results in partial embryonic lethality and an increase in
myocyte proliferation in late gestation, suggesting that Hopx,
perhaps in association with Hdac2, modulates the balance
between growth and differentiation pathways in the heart
(Chen et al., 2002; Shin et al., 2002).
Here we show that global loss of Hdac2 and Hopx in mice
leads to complete perinatal lethality, severe cardiac develop-
mental defects, and excessive myocyte proliferation. Hdac2
and Hopx regulate Gata4 acetylation and activation of Gata4-
dependent cell cycle genes. Our results suggest an unexpected
function for the homeodomain protein Hopx as an adaptor that
facilitates the ability of Gata4 to serve as a direct catalytic target
of Hdac2 in the embryonic heart.
RESULTS
Genetic Interaction between Hopx and Hdac2
Genetic inactivation of Hopx and Hdac2 separately results in
similar cardiac phenotypes characterized by partial embryonic
lethality and cardiac myocyte hyperplasia, and we have previ-
ously demonstrated that Hopx and Hdac2 physically interact
(Chen et al., 2002; Kook et al., 2003; Trivedi et al., 2007a). Hence,
we sought to determine whether Hopx and Hdac2 genetically
interact. Hdac2 is expressed by many, but not all, cardiac myo-
cytes at P0 (Figure 1A), where Hopx is also expressed
(Figure 1A). We crossed Hopx+/ mice with Hdac2+/ mice to
generate compound heterozygotes, which were intercrossed
to produce double homozygous knockout (DKO) offspring.DevelopmenDKO pups were identified at P0 when they appeared runted
and milk was not evident in the stomachs (Figure 1B). DKO
mice were not identified after P0 indicating complete perinatal
lethality (Table 1; see Table S1 available online). Compound
heterozygous mice were found alive postnatally and at weaning,
but several compound heterozygous animals appeared cyanotic
at birth (not shown) and were euthanized. Hematoxylin and
eosin–stained heart sections of these compound heterozygous
animals (Figure 1C) and of those lacking additional alleles of
Hopx orHdac2 (not shown) revealed severe muscular ventricular
septal defects (VSD), whereas these defects were never seen in
single heterozygous animals or wild-type controls. These data
suggest a genetic interaction between Hdac2 and Hopx. Exam-
ination of the hearts of DKO P0 pups revealed significant abnor-
malities in all cases (n = 6) with thickening of the ventricular walls
(Figure 1D). Cardiacmyocyte proliferation, as assessed by phos-
pho-histone H3 and myosin (MF-20) coimmunostaining, was
increased in both Hopx and Hdac2 single knockout hearts as
compared to wild-type littermates, and proliferation was even
more dramatically increased in DKO hearts, likely explaining
the thickened ventricular walls (Figures 1D and 1E).
Gata4 Target Genes Are Upregulated in DKO Hearts
We performed gene expression profiling of wild-type, Hdac2/,
Hopx/, and DKO hearts at E16.5 (Table S2). Gene ontogeny
analysis of significantly altered transcripts indicated that cell
cycle genes were markedly affected in both single and, to an
even greater extent, double knockout hearts (Figure S1A avail-
able online). Analysis of transcription factor–binding sites (using
the TRASFAC database) in the conserved noncoding regions
within 5 kb upstream of dysregulated genes in DKO hearts
revealed frequent GATA-binding sites, suggesting potential
direct Gata4 transcriptional targets (Figure S1B). Among these,
we confirmed that several cell cycle genes were upregulated in
DKOhearts byRT-PCR (TableS3), including transcripts of known
Gata4 targets, cyclinD2 andcdk4 (Figure 2A). Interestingly,Gata4
mRNA and protein levels were unaltered in Hopx and Hdac2
single knockout hearts and in DKO hearts (Figures 2B–2D).
Acetylation of Gata4 Is Modulated by Hopx and Hdac2
Gata4 transcriptional activity is known to be regulated by post-
translational modifications (Kawamura et al., 2005; Liang et al.,
2001). Gata4 is acetylated by p300, which results in enhanced
transcriptional activity (Kawamura et al., 2005; Takaya et al.,
2008). Immunoprecipitation of endogenous Gata4 protein from
wild-type and DKO hearts followed by western blotting using
an antiacetylated lysine-specific antibody indicated that acety-
lated Gata4 was significantly upregulated in DKO hearts
compared to controls and single knockouts (Figures 3A
and 3B). Transfection experiments in 293T cells followed by
anti-HA Gata4 immunoprecipitation and anti–acetyl lysine
immunoblotting confirmed that acetylated Gata4 levels are
diminished by cotransfection of Hdac2 (Figures 3C and 3D).
Transfection of Hopx alone results in mild diminution of the
acetylated Gata4 signal (Figures 3C and 3D). However, cotrans-
fection of both Hdac2 and Hopx markedly reduced acetylated
Gata4 levels (Figures 3C and 3D). Importantly, transfection of
a mutant form of Hopx that does not interact with Hdac2, termed
HopxH2 (Kook et al., 2003), does not reduce acetylatedtal Cell 19, 450–459, September 14, 2010 ª2010 Elsevier Inc. 451
Figure 1. Myocardial Defects in Hdac2-Hopx Null Mice
(A) Immunohistochemistry (Hdac2) and LacZ staining (Hopx) of P0 HopxlacZ/+ heart sections shows Hdac2 and Hopx coexpression (arrow) in developing heart.
(B) Wild-type and Hdac2-Hopx DKO littermates are shown at P0. Arrows point to stomach.
(C) Hematoxylin and eosin–stained sections of wild-type and compound heterozygous hearts show muscular type of ventricular septal defect (VSD) at P0.
(D) Abnormally thickened compact zone of the ventricular myocardium and increased cardiac myocyte proliferation in DKO hearts. Immunohistochemistry stain-
ing of Hdac2 shows loss of Hdac2 in DKO hearts at P0.Hopx in situ shows loss ofHopxmRNA in DKO hearts at P0. Cardiac myocyte proliferation (green, stained
by MF-20) was assessed by phosphohistone H3 costaining (arrows) in wild-type, Hdac2/, Hopx/, and DKO P0 hearts. Scale bar, 20 mm.
(E) Quantification of phospho-histone H3 positive cells in WT, compound heterozygous,Hdac2/,Hopx/, and DKO P0 cardiac myocytes (mean ± SEM, n = 3).
N.S., not significant.
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Hdac2 (Figures 3C and 3D).
Gata4 is able to activate expression of cyclinD2 and cdk4 by
binding to promoter/enhancer regions, resulting in direct trans-
activation (Rojas et al., 2008). Hence, we examined the ability
of Hopx and Hdac2 to modify Gata4 activation of appropriate
cyclinD2 and cdk4 luciferase reporter constructs. Transfection
of Gata4 resulted in an approximate 10-fold activation of the
cyclinD2 reporter, and this activation was moderately impaired
by cotransfection of either Hdac2 or Hopx alone (Figure 3E).
Cotransfection of Hopx and Hdac2 together markedly inhibited
Gata4-mediated transactivation (Figure 3E). Mutant HopxH2
did not inhibit Gata4-dependent transactivation, nor did it
enhance suppression of Gata4-dependent transactivation
when cotransfected with Hdac2 (Figure 3E).
Gata4 contains four lysine residues near the second zinc
finger, at positions 311, 318, 320, and 322, that are potentially
capable of acetylation (Takaya et al., 2008). Replacement of
lysines with alanine to mimic deacetylation resulted in a mutant
form of Gata4 that could only weakly transactivate the cyclinD2
luciferase reporter (Figure 3E). Replacement of lysine residues
with glutamine to mimic constitutive acetylation allowed for
approximately 7-fold activation of the cyclinD2-luciferase452 Developmental Cell 19, 450–459, September 14, 2010 ª2010 Elsreporter. Importantly, cotransfection of Hdac2, Hopx, or both
together failed to inhibit activation induced by this K/Q mutant
(Figure 3E). Similar results were obtained using cdk4 and ANF-
luciferase reporter constructs (data not shown). These results
suggest that Hdac2 and Hopx function, at least in part, by medi-
ating deacetylation of lysine residues within Gata4 to modulate
transcriptional activity.
Hdac2 and Gata4 Physically Interact
Immunoprecipitation of Gata4 protein from heart lysates,
followed by immunoblotting for Hdac2, indicates that Gata4
and Hdac2 proteins can interact in vivo (Figure 4A). This interac-
tion was markedly less robust when tested in heart lysates taken
from Hopx/ embryos, consistent with a model in which
a complex containing Hdac2 and Gata4 is stabilized by Hopx
(Figures 4A and 4B). In transfected 293T cells, Gata4 and
Hdac2 can also interact (Figure 4C), and this interaction is stabi-
lized by adding increasing amounts of Hopx (Figures 4C and 4D).
Deletion analysis indicates that the interaction between Hdac2
and Hopx requires the lysine rich domain of Gata4 and is specific
(Figures 4E and 4F). Loss of this interaction between Gata4 and
Hdac2 abolishes Hdac2-Hopx–mediated repression of Gata4-
dependent cyclinD2 reporter activity (Figure 4G).evier Inc.










Hdac2+/+ Hopx+/+ 22 5.8 20.25 6.3
Hdac2/Hopx/ 0 0.0 20.25 6.3
Hdac2+/+Hopx/ 33 8.7 20.25 6.3
Hdac2/Hopx+/+ 8 2.1 20.25 6.3
Hdac2+/+Hopx+/ 71 18.7 40.5 12.5
Hdac2/Hopx+/ 10 2.6 40.5 12.5
Hdac2+/Hopx+/+ 49 12.9 40.5 12.5
Hdac2+/Hopx/ 73 19.2 40.5 12.5
Hdac2+/Hopx+/ 114 30.0 81 25.0
Parents of these mice were Hdac2+/ Hopx+/.
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Gata4
Prior experimental data have suggested that a phosphorylated
form of Hdac2 preferentially occupies promoter regions of regu-
lated genes, whereas an unphosphorylated form is more
commonly found at coding regions of transcribed genes
(Sun et al., 2007). Hence, we sought to determine whether
a phosphorylated form of Hdac2 preferentially interacts with
Gata4 to mediate deacetylation and regulation of downstream
gene transcription. We generated a mutant form of Hdac2 inDevelopmenwhich serine residues 394, 411, 422, and 424 are mutated to
alanine to prevent serine phophorylation. This mutant form of
Hdac2 failed to robustly interact with Gata4 (Figure 5A and 5B)
and failed to repress Gata4-mediated activation of luciferase
reporter constructs (Figure 5C). The Hdac2 phospho mutant
was expressed at equivalent levels when compared to wild-
type Hdac2 (Figure 5A) and was equally able to mediate deace-
tylation of histoneH3 and a histone pseudo-substrate in an
in vitro Hdac activity assay (Figures 5D–5F), suggesting that
catalytic activity was intact. Taken together, these results
suggest that Hdac2 functions coordinately with Hopx to deace-
tylate Gata4 and thus regulate transcriptional activity and myo-
cyte proliferation in the developing heart (Figure 5G).
DISCUSSION
In this report, we demonstrate a genetic and functional interac-
tion between Hdac2 and Hopx. Heterozygous inactivation of
either gene is well tolerated without any noted phenotype,
whereas compound heterozygous mice exhibit muscular
VSDs. This type of VSD is unusual in mouse models, whereas
membranous VSDs located at the superior margin of the inter-
ventricular septum are more common, and suggests a defect
of myocyte development. Mice homozygous deficient for both
Hdac2 and Hopx exhibit perinatal lethality and cardiac myocyte
proliferation is markedly upregulated. The resulting ventricular
walls are thickened and hyperplastic. Genes involved inFigure 2. Aberrant Expression of Gata4
Target Genes in DKO Hearts
(A) Transcripts for Gata4 target genes, cyclinD2
and cdk4, were detected by qRT-PCR from
E16.5 wild-type, Hdac2/, Hopx/, and DKO
myocardium (mean ± SEM, n = 3).
(B) Gata4 transcripts were detected by qRT-PCR
from E16.5 wild-type, Hdac2/, Hopx/, and
DKO myocardium (mean ± SEM, n = 3).
(C) Gata4 protein levels are unchanged in DKO
mice. Gata4 expression was assessed by immu-
nohistochemistry in WT and DKO E16.5 hearts.
Scale bar, 10 mm.
(D) Western blot analysis was performed on total
lysates from WT, DKO, Hdac2/, and Hopx/
E16.5 hearts. b-actin is shown as a loading
control. N.S., not significant.
tal Cell 19, 450–459, September 14, 2010 ª2010 Elsevier Inc. 453
Figure 3. Hdac2-Hopx Modulates Gata4 Transcriptional Activity and
Acetylation
(A) Increased Gata4 acetylation in DKO hearts. Total lysates from E16.5 WT,
DKO, Hdac2/, and Hopx/ hearts were immunoprecipitated by anti-Gata4
antibody, and western blot was performed using anti-acetyl lysine antibody to
detect acetylated Gata4. Western blot for total Gata4 is shown below.
(B) Acetylated Gata4 was quantified and normalized to total Gata4 in WT,
DKO, Hdac2/, and Hopx/ myocardium using ImageJ software
(mean ± SEM, n = 3).
(C) Hdac2-Hopx overexpression inhibits Gata4 acetylation. Total lysates from
transfected 293T cells were immunoprecipitated by anti-HA antibody to immu-
noprecipitate Gata4, and acetylated Gata4 was detected by western blot
analysis using anti–acetyl lysine antibody.
(D) Acetylated Gata4 was quantified and normalized to total Gata4 using
ImageJ software (mean ± SEM, n = 3).
(E) Hdac2-Hopx inhibits Gata4-dependent transactivation. CyclinD2-lucif-
erase reporter construct was transfected in H9c2 myoblast cells with or
without Gata4, Hdac2, Hopx, HopxH2, Gata4KA, and Gata4KQ expression
constructs. Firefly luciferase activity was measured from total lysates 24 hr
after transfection and was normalized to renilla luciferase activity. The induc-
tion is represented as fold-induction over the normalized luciferase activity
in the untreated cells (mean ± SEM, n = 3). N.S., not significant.
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454 Developmental Cell 19, 450–459, September 14, 2010 ª2010 Elsembryonic cardiac myocyte proliferation are upregulated. Our
data strongly suggest that this is due, at least in part, to
enhanced Gata4 transcriptional activity, which in turn is due to
Gata4 hyper-acetylation. Furthermore, our results suggest that
a phosphorylated form of Hdac2 interacts with Gata4 in
a complex that is stabilized by Hopx (Figure 5G).
Hdacs are commonly thought to act as transcriptional co-
repressors by deacetylating histone tails with resulting compac-
tion of chromatin structure. Nonhistone targets of Hdacs have
been described, raising the possibility that Hdac-mediated
effects on transcription can be caused by catalytic activity or
other mechanisms unassociated with chromatin remodeling.
Our results demonstrating that a Gata4 mutant in which lysine
residues are mutated to mimic constitutive acetylation cannot
be inhibited by Hdac2 allow us to conclude that direct deacety-
lation of Gata4, rather than deacetylation of histones, is respon-
sible for Hdac2-mediated repression of Gata4 in this system.
Regulation of cardiac growth and proliferation requires a deli-
cate balance of gene transcription and regulation of cell cycle
machinery. Several transcription factors and cofactors maintain
this balance during cardiac development (Pasumarthi and Field,
2002), and Hopx has previously been implicated in this process
(Chen et al., 2002; Shin et al., 2002). Loss of either Hopx or
Hdac2 individually leads to partially penetrant embryonic
lethality with increased cardiomyocyte proliferation (Chen
et al., 2002; Shin et al., 2002; Trivedi et al., 2007a). The results
of the present study elucidate a mechanistic pathway by which
an Hdac2-Hopx complex regulates embryonic myocardial prolif-
eration. Overlapping features of the individual knockouts, the
genetic interaction (particularly that seen in compound heterozy-
gotes), and shared downstream target genes evident from
microarray analysis are all consistent with this model. However,
Hdac2 and Hopx individual knockout mice also have significant
differences in their phenotypes, and microarrays suggest
distinct downstream genes in addition to those that are shared.
Thus, each is likely to have functions that are independent of
activities within a shared complex (Chen et al., 2002; Shin
et al., 2002; Trivedi et al., 2007a).
The fact that DKO mice have a worse phenotype than either
Hopx or Hdac2 individual nulls indicates that neither protein is
absolutely required for the activity of a shared complex. The
data presented here suggest that Hopx stabilizes the interaction
between Hdac2 and Gata4 and enhances Gata4 deacetylation,
and we hypothesize that some degree of Hdac-mediated Gata4
deacetylation is preserved in the absence of Hopx. Likewise,
when Hdac2 is absent, some degree of Gata4 deacetylation is
still evident when compared to the absence of both Hopx and
Hdac2 (both in vivo and in transfected cells, Figure 3B), and we
hypothesize that this is due to partially redundant functions of
other Hdacs. Indeed, we have previously shown that Hopx can
interact with Hdac3 (Kook et al., 2003) and Hdac1 shares exten-
sive homology with Hdac2 (de Ruijter et al., 2003).
Previous reports have indicated that Gata factors can recruit
Hdacs to target genes, either by directly interacting or by asso-
ciating with Fog (Friend of Gata) proteins that can recruit the
NuRD complex containing Hdac1 and Hdac2 (Cantor and Orkin,
2005; Hong et al., 2005; Svensson et al., 1999; Tsang et al.,
1997). For example, Hdac3 interacts with Gata2 to mediate tran-
scriptional repression in hematopoietic progenitor cells (Ozawaevier Inc.
Figure 4. Hdac2 Interacts with Gata4
(A) Total lysates from E16.5 WT and Hopx/ hearts were immunoprecipitated by anti-Gata4 antibody, and western blot was performed using anti-Hdac2 anti-
body. The interaction between Hdac2 and Gata4 is more robust in WT hearts (lane 2) than in Hopx-deficient hearts (lane 3).
(B) Quantification of the interaction between Hdac2 and Gata4 in WT and Hopx/ hearts using ImageJ software (mean ± SEM, n = 3).
(C) Hopx modulates Hdac2-Gata4 interaction. Total lysates from transfected 293T cells were immunoprecipitated by anti-HA antibody to immunoprecipitate
Gata4, and western blot was performed with anti-Flag antibody to detect Hdac2. Increasing amounts of Hopx resulted in an increasingly robust interaction
between Hdac2 and Gata4.
(D) Quantification of the interaction between Hdac2 and Gata4 in presence of increasing amount of Hopx (mean ± SEM, n = 3).
(E) Schematic representation of Gata4 showing posttranslational modification sites and deletion constructs. Gata4 contains two distinct zinc (Zn) finger domains
and two transcriptional activation domains (TAD). Gata4 also contains lysine rich domain (K) and nuclear localization sequence (NLS). p300-dependent acety-
lation of Gata4 at Lys 311, 318, 320, and 322 andMAPK-dependent phosphorylation at Ser105 are important for Gata4 DNA binding and transcriptional activation
abilities.
(F) Total lysates from Gata4 or various Gata4 deletion constructs transfected 293T cells were immunoprecipitated with anti-HA antibody, and western blot anal-
ysis was performed with anti-Hdac2 antibody to detect Hdac2. n.s., nonspecific.
(G) Loss of Hdac2 and Gata4 interaction prevents Hdac2-Hopx mediated repression of Gata4-dependent cyclinD2 reporter activity.CyclinD2-luciferase reporter
construct was transfected in H9c2 cells with or without Gata4, Gata4D241-274, Hdac2, and Hopx expression constructs. Firefly luciferase activity wasmeasured
from total lysates 24 hr after transfection and was normalized to renilla luciferase activity. The induction is represented as percentage activity of cyclinD2 reporter
over the normalized luciferase activity in the Gata4 or Gata4 D241-274 transfected cells (mean ± SEM, n = 3).
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reduced Gata1 transcriptional activity (Watamoto et al., 2003).
In each case, Hdac function suppresses Gata-dependent tran-
scriptional activity. Although it was generally assumed that
Hdac-mediated transcriptional repression of Gata activity was
mediated by histone deacetylation and chromatin remodeling,
it will be interesting to readdress this question in light of our
results to determine whether other Gata proteins are regulated
by Hdacs via direct deacetylation.
The present study focused on the role of Hopx and Hdac2
during embryonic cardiac development. However, our prior
studies have implicated important roles for both Hopx and
Hdac2 in the adult heart (Chen et al., 2002; Kook and Epstein,Developmen2003; Kook et al., 2003, 2006; Trivedi et al., 2007a). Gata4 also
functions in homeostasis of the adult myocardium, and alter-
ations in transcriptional activity, including those regulated by
p300-mediated acetylation of Gata4, affect adult cardiac hyper-
trophy (Takaya et al., 2008). However, the model presented here
to explain the roles of Hopx, Hdac2, and Gata4 in regulation of
embryonic myocardial proliferation cannot easily explain the
roles for these proteins during adult cardiac hypertrophic
processes. Hdac2 deficiency results in resistance to cardiac
hypertrophy, and Hopx overexpression induces hypertrophy.
Cardiac hypertrophy is generally associated with enhanced
Gata4 activity (which drives cardiac structural gene expression).
A simple extension of the model presented here would suggesttal Cell 19, 450–459, September 14, 2010 ª2010 Elsevier Inc. 455
Figure 5. Phosphorylated Hdac2 Preferentially Interacts with Gata4 and Modulates Transcriptional Activity
(A) Total lysates from transfected 293T cells were immunoprecipitated with anti-Hdac2 antibody to immunoprecipitate Hdac2, and western blot analysis was
performed with anti-Gata4 antibody. Mutation of serine 394, 411, 422, and 424 of Hdac2 to alanine (Hdac2SA) reduced interaction with Gata4.
(B) Quantification of the interaction between phospho mutant Hdac2 and Gata4 using ImageJ software (mean ± SEM, n = 3).
(C) CyclinD2-luciferase reporter construct was transfected in H9c2 myoblast cells with or without Gata4, Hdac2, Hopx, and Hdac2SA expression constructs.
Normalized luciferase activity is reported as fold-induction over mock-transfected cells (mean ± SEM, n = 3).
(D) Hdac2SA retains deacetylase activity. Total lysates from transfected 293T cells with or without Hdac2 and Hdac2SA were assayed for HDAC activity against
a pseudosubstrate (mean ± SEM, n = 3).
(E) Western blot analysis was performed on total lysates from transfected 293T cells with or without Hdac2 or Hdac2SA using an antiacetylated histoneH3 anti-
body. Hdac2 expression was determined by using an anti-Hdac2 antibody that recognized endogenous (lane 1) and exogenous Hdac2. Transfection of either
Hdac2 or Hdac2SA resulted in diminished histoneH3 acetylation compared to mock-transfected cells.
(F) Acetylated histoneH3 was quantified and normalized to total histoneH3 in Hdac2 or Hdac2SA transfected cells using ImageJ software (mean ± SEM, n = 3).
(G) Model depicting Hdac2 interacting with Hopx to induce deacetylation of Gata4 and modulation of cell cycle genes.
Developmental Cell
Hopx and Hdac2 Regulate Myocyte Proliferationthat loss of Hdac2 would result in enhanced Gata4 activity, and
gain of Hopx might produce an inhibition of Gata4 activity.
Neither of these predictions would be consistent with the adult
phenotypes. However, we have noted a dramatic loss of Gata4
protein in newborn mice lacking Hopx and Hdac2, suggesting
that hyper-acetylation results in protein degradation, with result-
ing loss of Gata4 activity. Consistent with this hypothesis,
acetylation of Gata1 enhances activity and simultaneously
accelerates degradation (Hernandez-Hernandez et al., 2006).
Future studies will attempt to elucidate the mechanisms by
which acetylation of Gata4 leads to degradation and the degree
to which this pathway can account for the adult cardiac hyper-
trophy phenotypes in Hdac2 and Hopx mice.
Gata4 contains two distinct zinc finger domains and
a C-terminal nuclear localization sequence that together consti-
tute the DNA binding and protein-protein interaction domain
(Molkentin, 2000). Gata4 also contains two transcriptional acti-
vation domains in the N terminus (Pikkarainen et al., 2004).456 Developmental Cell 19, 450–459, September 14, 2010 ª2010 ElsSome of these Gata4 domains are known to interact with other
transcription factors or cofactors. For example, Gata4 interacts
with p300 at the second zinc finger, with Fog2 at the first zinc
finger, and with Gata6 at the region including both zinc fingers
and their C-terminal tails (Charron et al., 1999; Dai andMarkham,
2001; Lu et al., 1999; Svensson et al., 1999). Our studies identify
the lysine-rich domain located between the two zinc fingers as
the region necessary for interaction with Hdac2.
Several HDACs are known to be regulated by phosphorylation
(Haberland et al., 2009). Casein kinase II (CKII) is a putative
Hdac2 kinase that can phosphorylate Hdac2 at Ser394, Ser422,
and Ser424 (Adenuga et al., 2009; Tsai and Seto, 2002). Although
the majority of Hdac2 in the cell is unphosphorylated, a recent
study suggests that the phosphorylated form preferentially asso-
ciates with mSin3A, NuRD, and CoREST complexes that are
recruited to promoter regions by transcription factors such as
p53, pRb, YY1, and NF-kappaB (Sun et al., 2007). Our data
suggest that phosphorylated Hdac2 interacts with Gata4,evier Inc.
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tional activity. Thus, phosphorylation of Hdac2, by CKII or by
another Hdac kinase in the heart, may serve as a mode of regu-
lation of Gata4 activity and myocyte proliferation.
EXPERIMENTAL PROCEDURES
Generation of Hdac2-Hopx DKO Mice
Hdac2 null and Hopx null mice have been described elsewhere (Chen et al.,
2002; Trivedi et al., 2007a). We interbred Hdac2+/ mice with Hopx+/ mice
to generate Hdac2+/; Hopx+/. These compound heterozygous mice were
crossed to generate Hdac2-Hopx DKO mice.
Histology, Immunohistochemistry, and In Situ Hybridization
Tissues were fixed in 2% paraformaldehyde, ethanol dehydrated, embedded
in paraffin, and sectioned as described elsewhere (Trivedi et al., 2007a). Proto-
cols for hematoxylin and eosin staining and immunohistochemistry have been
described elsewhere (Trivedi et al., 2007a). E16.5 and P0wild-type, compound
heterozygous, Hdac2 null, Hopx null, and Hdac2-Hopx DKO heart sections
were deparaffinized and pretreated using heat antigen retrieval with Bull’s
Eye Decloaker (BioCare Medical). After blocking endogenous peroxidase
with 3% hydrogen peroxide, washing with 0.1% PBST, and blocking with
2.5% horse serum, sections were incubated with anti-phospho-histone H3
(1:50; Cell Signaling) antibody overnight at 4C. After washing with 0.1%
PBST, sections were incubated with biotinyl tyramide amplification reagent
(TSA Biotin System, PerkinElmer) at 25C for four minutes, washed with
0.1% PBST, and incubated with steptavidin-Texas red (1:500; PerkinElmer)
for 1 hr at 25C. For MF-20 (myosin) costaining, these sections were incubated
with anti-MF-20 (1:20, Developmental Studies Hybridoma Bank) overnight at
4C after washing with 0.1% PBST and blocking with 10% goat serum. Alexa
Fluor 488 goat anti-mouse IgG (1:250; Invitrogen) was used as a secondary
antibody. Slides were washed with 0.1% PBST and mounted with Vectashield
mounting medium (Vector Laboratories). Using ImageJ software, phospho-
histone H3-positivemyocyte nuclei that were alsoMF20 positive were counted
in five different sections of three independent heart samples. In situ hybridiza-
tion was performed on paraffin sections using S35 labeledHopx RNA probe, as
described elsewhere (Chen et al., 2002).
Microarray, Gene Ontology Analysis, and Real-Time PCR
Microarray analysis was performed using three independent samples of wild-
type, Hdac2 null, Hopx null, or Hdac2-Hopx DKO ventricular cardiac tissue
from E16.5 embryos. RNA was extracted and reverse transcribed without
amplification. Microarray analysis was performed by the University of Pennsyl-
vania Microarray Core Facility using Affymetrix mouse cDNA arrays (MOE430
v2.0). Full data sets are available at Gene Expression Omnibus (GEO, acces-
sion number GSE23700) (Barrett et al., 2009). Gene ontology analysis was
performed with Database for Annotation, Visualization and Integrated
Discovery 6.7 (DAVID 6.7, http://david.abcc.ncifcrf.gov/) using PANTHER
annotation (Panther_BP_All) with medium stringency (Dennis et al., 2003).
Quantitative real time PCR (qRT-PCR) was performed as described else-
where (Trivedi et al., 2008a). Briefly, total RNA was isolated from dissected
mouse heart ventricles using Trizol (Invitrogen). RNA was reverse-transcribed
using random hexamers and the Superscript First Strand Synthesis Kit (Invitro-
gen). Gene expression was then evaluated by qRT-PCR (ABI PRISM 7900)
using the SYBR Green (Applied Biosystems). Signals were normalized to their
corresponding GAPDH controls, and the ratios were expressed as fold
changes compared to wild-type controls. PCR conditions and primer set
sequences are available upon request.
Immunoprecipitation
Embryonic heart samples or 293T cells were homogenized in immunoprecip-
itation buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.5% Nonidet P-40,
1 mM EDTA, and 1 mM DTT) containing 1 mM PMSF, phosphatase inhibitors
(Sigma), and protease inhibitors mixture (Sigma). The samples were sonicated
five times for 3 s. The lysate was collected by centrifugation at 16,000 3 g for
10min at 4C. Precleared lysates with beads were incubated with primary anti-
bodies for 16 hr at 4C. After incubation for 1 hr at 4C with beads, immuno-Developmencomplexes were collected, washed four times with immunoprecipitation
buffer, and applied to 4%–12% SDS-polyacrylamide gels for western blot
analysis.Western Blotting
Heart tissue lysates and cell lysates were prepared in lysis buffer consisting of
20 mmol/L Tris HCl (pH 7.5), 150 mmol/L NaCl, 1 mmol/L Na2EDTA, 1 mmol/L
EGTA, 1% Triton X-100, 1 mg/mL leupeptin, 2.5 mmol/L sodium pyrophos-
phate, 1 mmol/L Na3VO4, and 1 mmol/L b-glycerophosphate; 1 mmol/L
phenylmethylsulfonyl fluoride was added before use. Equal amounts of protein
were resolved by 4%–12%SDS-PAGE acrylamide gel and were transferred to
poly(vinylidene difluoride) membranes. We used primary antibodies to Gata4
(1:1000 dilution, SantaCruz), Hdac2 (1:1000 dilution, Invitrogen), acetyl lysine
(1:1000 dilution, Upstate), FLAG (1:1000 dilution, Sigma), Myc (1:1000 dilution,
Sigma), HA (1:1000 dilution, SantaCruz), histone H3 (1:1000 dilution, Upstate),
and acetylated histone H3 (1:1000 dilution, Upstate). Primary antibody binding
was visualized by HRP-conjugated secondary antibody and detected by
enhanced chemiluminescence (LumiGlo, Cell Signaling). Membranes were re-
probed with primary antibody against b-actin (1:2500 dilution, Sigma) for
loading control.Transient Transfections and Luciferase Assays
H9c2 myoblasts and 293T cells were transfected with PolyFect transfection
reagent (QIAGEN) as permanufacturer’s protocol. In brief, for H9c2myoblasts,
each 100-mm plate containing a subconfluent culture was transfected with
total of 4 mg of DNA and 25 ml of PolyFect transfection reagent in 8 ml of
10% FBS medium. Total DNA was maintained constant by adding empty
pcDNA3.1+ vector when appropriate. Twenty-four hours after transfection,
cells were lysedwith passive lysis buffer (Promega), and lysates were analyzed
for both firefly and renilla luciferase activity using a dual luciferase reporter
assay kit (Promega), as described elsewhere (Trivedi et al., 2008b). Perki-
nElmer multilabel plate reader was used to determine luciferase activity
according to the manufacturer’s instructions. For 293T cells, each 100-mm
plate containing a subconfluent culture was transfected with total of 8 mg of
DNA and 25 ml of PolyFect transfection reagent in 8 ml of 10% FBS medium.Plasmids and Site-Directed Mutagenesis
Plasmids for expression of Hdac2, Hopx, and Gata4 are described elsewhere
(Durocher et al., 1997; Kook et al., 2003; Trivedi et al., 2007a). Various deletion
mutants of HA-tagged Gata4 cDNA were created by PCR amplification,
sequence verified, and subcloned into the pGC eukaryotic expression vector
(Durocher et al., 1997). The Gata4 N-terminal deletion mutants, pG4D80N,
pG4D129N, and pG4D240N were named according to the last amino acid of
the full-length protein that was deleted. Similarly, the C-terminal deletion
mutants, pG4D390C, pG4D336C, pG4D310C, and pG4D274C were named
to indicate the most C-terminal amino acid present in the recombinant protein.
Finally, the in-frame GATA-4 deletion mutant, pG4D241-274N, was named to
indicate the N- and C-terminal boundaries of the specified deletion. Plasmids
HA-Gata4-KA (K311A/K318A/K320A/K322A), HA-Gata4-KQ (K318Q/K320Q/
K322Q), and Hdac2SA (S394A/S411A/S422A/S424A) were used to generate
Gata4KA, Gata4KQ and Hdac2SA, respectively, and were constructed by
using a site-directed mutagenesis kit as per the manufacturer’s protocol (Stra-
tagene). HopxH2 (HopH2) has been described elsewhere (Kook et al., 2003).
All the constructs were sequenced and tested for expression by western
blot analysis following transient transfection in 293T cells.HDAC Activity Assay
HDAC activity was measured by using an HDAC activity assay kit for fluoro-
metric detection (Upstate) according to the manufacturer’s protocol, as
described elsewhere (Trivedi et al., 2007b). In brief, H9c2 or 293T cells were
transfected with plasmid containing either Hdac2 or mutant Hdac2SA. Thirty
micrograms of total extract was incubated with HDAC assay substrate and
incubated at 30C for 60 min. After addition of diluted activator reagent,
samples were incubated at room temperature for 15 min and examined by
fluorescent microplate reader at excitation of 360 nm and emission 450 nm.
A standard curve was performed according to the manufacturer’s protocol.tal Cell 19, 450–459, September 14, 2010 ª2010 Elsevier Inc. 457
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Data are expressed as mean ± SEM unless otherwise stated. The statistical
significance of differences between groupswas analyzed by Student’s 2-tailed
t test. Differences were considered significant at a p < 0.05.
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